{"id":17947,"date":"2025-07-18T13:12:11","date_gmt":"2025-07-18T13:12:11","guid":{"rendered":"https:\/\/itbusinesstoday.com\/?p=17947"},"modified":"2025-07-18T13:12:11","modified_gmt":"2025-07-18T13:12:11","slug":"re-air-raises-%c2%a5580m-for-vascular-regeneration-therapy","status":"publish","type":"post","link":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/re-air-raises-%c2%a5580m-for-vascular-regeneration-therapy\/","title":{"rendered":"\u30ea\u30fb\u30a8\u30a2\u3001\u8840\u7ba1\u518d\u751f\u6cbb\u7642\u30675\u51048000\u4e07\u5186\u3092\u8abf\u9054"},"content":{"rendered":"<?xml encoding=\"utf-8\" ?><p>Tokyo biotech startup Reair Inc., which spun out from Juntendo University, has raised &yen;685 million in pre-series A funding. This funding will help advance its regenerative medicine platform. Eight entities invested in the funding round. They included TOPPAN Holdings, Hisamitsu Pharmaceutical, and Asahi Group Japan.<\/p><p>Reair is working on RE-01, a cell therapy. It uses a patient&rsquo;s own peripheral blood mononuclear cells. This treatment targets refractory ischemic lower limb ulcers. These ulcers are tough to treat with standard methods. The funds will help support the next phase of clinical trials. These investigator-initiated trials are set for 2025. Early trials showed promising results: complete healing of ulcers, less pain, and no harmful events from the therapy. This indicates it is both safe and effective.<\/p><p>Reair will also pursue clinical research for RC-01. This product is an autologous cell-based treatment aimed at diseases linked to microvascular dysfunction. It falls under Japan&rsquo;s Act on the Safety of Regenerative Medicine.<\/p><h4>\u3053\u3061\u3089\u3082\u304a\u8aad\u307f\u304f\u3060\u3055\u3044\uff1a <a class=\"p-url\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/bluememe-invests-in-medivally-for-medical-innovation\/\" rel=\"bookmark\">BlueMeme\u3001\u533b\u7642\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u306e\u305f\u3081\u306bMediVally\u306b\u6295\u8cc7<\/a><\/h4><p>\u4eca\u56de\u306e\u8cc7\u91d1\u63d0\u4f9b\u306f\u3001\u60a3\u8005\u56fa\u6709\u306e\u518d\u751f\u6cbb\u7642\u306b\u3068\u3063\u3066\u5927\u304d\u306a\u4e00\u6b69\u3067\u3059\u3002\u6162\u6027\u8840\u7ba1\u75be\u60a3\u306b\u5bfe\u3059\u308b\u7d30\u80de\u6cbb\u7642\u3078\u306e\u95a2\u5fc3\u304c\u9ad8\u307e\u3063\u3066\u3044\u308b\u3053\u3068\u3092\u793a\u3057\u3066\u3044\u307e\u3059\u3002 <a href=\"https:\/\/www.re-eir.com\/\" data-no-translation=\"\">Reair&nbsp;<\/a> \u306f\u3001\u305d\u306e\u79d1\u5b66\u6027\u3092\u8a3c\u660e\u3057\u3001\u898f\u5236\u3092\u6e80\u305f\u3059\u3053\u3068\u306b\u91cd\u70b9\u3092\u7f6e\u3044\u3066\u3044\u307e\u3059\u3002\u305d\u3046\u3059\u308b\u3053\u3068\u3067\u3001\u81e8\u5e8a\u3067\u3088\u308a\u5e83\u304f\u53d7\u3051\u5165\u308c\u3089\u308c\u308b\u3088\u3046\u306b\u306a\u308b\u3067\u3057\u3087\u3046\u3002<\/p>","protected":false},"excerpt":{"rendered":"<p>Tokyo biotech startup Reair Inc., which spun out from Juntendo University, has raised &yen;685 million in pre-series A funding. This funding will help advance its regenerative medicine platform. Eight entities invested in the funding round. They included TOPPAN Holdings, Hisamitsu Pharmaceutical, and Asahi Group Japan.Reair is working on RE-01, a cell therapy. It uses a patient&rsquo;s own peripheral blood mononuclear cells. This treatment targets refractory ischemic lower limb ulcers. These ulcers are tough to treat with standard methods. The funds will help support the next phase of clinical trials. These investigator-initiated trials are set for 2025. Early trials showed promising results: complete healing of ulcers, less pain, and no harmful [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":17956,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"wprm-recipe-roundup-name":"","wprm-recipe-roundup-description":"","postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"footnotes":""},"categories":[208,1,89,198,211,237,182,1838,206],"tags":[6356,641,6357,592,873,1343],"ppma_author":[572],"class_list":["post-17947","post","type-post","status-publish","format-standard","has-post-thumbnail","category-apac","category-fintech","category-health-tech","category-investments","category-japan","category-news","category-pharma","category-quick-reads","category-regional","tag-blood-vessel-regeneration","tag-investment","tag-reair","tag-regenerative-medicine","tag-series-a-funding","tag-startup"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Re-air Secures \u00a5580M for Blood Cell-Based Vascular Therapy<\/title>\n<meta name=\"description\" content=\"Reair, a Juntendo University startup, raised \u00a5685M to advance medicine using patients\u2019 peripheral blood, backed by eight major investors.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/re-air-raises-\u00a5580m-for-vascular-regeneration-therapy\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Re-air Secures \u00a5580M for Blood Cell-Based Vascular Therapy\" \/>\n<meta property=\"og:description\" content=\"Reair, a Juntendo University startup, raised \u00a5685M to advance medicine using patients\u2019 peripheral blood, backed by eight major investors.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/re-air-raises-\u00a5580m-for-vascular-regeneration-therapy\/\" \/>\n<meta property=\"og:site_name\" content=\"itbusinesstoday\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-18T13:12:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/07\/Re-air-Raises-\u00a5580M-for-Vascular-Regeneration-Therapy-01.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1201\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"ITBT StaffWriter\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"ITBT StaffWriter\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30ea\u30a8\u30a2\u30fc\u3001\u8840\u6db2\u7d30\u80de\u3092\u7528\u3044\u305f\u8840\u7ba1\u6cbb\u7642\u30675\u51048000\u4e07\u5186\u3092\u7372\u5f97","description":"\u9806\u5929\u5802\u5927\u5b66\u767a\u306e\u30b9\u30bf\u30fc\u30c8\u30a2\u30c3\u30d7\u3001\u30ea\u30a8\u30a2\u304c6\u51048500\u4e07\u5186\u3092\u8abf\u9054\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/re-air-raises-\u00a5580m-for-vascular-regeneration-therapy\/","og_locale":"ja_JP","og_type":"article","og_title":"Re-air Secures \u00a5580M for Blood Cell-Based Vascular Therapy","og_description":"Reair, a Juntendo University startup, raised \u00a5685M to advance medicine using patients\u2019 peripheral blood, backed by eight major investors.","og_url":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/re-air-raises-\u00a5580m-for-vascular-regeneration-therapy\/","og_site_name":"itbusinesstoday","article_published_time":"2025-07-18T13:12:11+00:00","og_image":[{"width":1201,"height":800,"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/07\/Re-air-Raises-\u00a5580M-for-Vascular-Regeneration-Therapy-01.webp","type":"image\/webp"}],"author":"ITBT StaffWriter","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"ITBT StaffWriter","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/re-air-raises-%c2%a5580m-for-vascular-regeneration-therapy\/#article","isPartOf":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/re-air-raises-%c2%a5580m-for-vascular-regeneration-therapy\/"},"author":{"name":"ITBT StaffWriter","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15"},"headline":"Re-air Raises \u00a5580M for Vascular Regeneration Therapy","datePublished":"2025-07-18T13:12:11+00:00","mainEntityOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/re-air-raises-%c2%a5580m-for-vascular-regeneration-therapy\/"},"wordCount":211,"publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/re-air-raises-%c2%a5580m-for-vascular-regeneration-therapy\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/07\/Re-air-Raises-\u00a5580M-for-Vascular-Regeneration-Therapy-01.webp","keywords":["Blood vessel regeneration","Investment","Reair","regenerative medicine","Series A funding","startup"],"articleSection":["APAC","FinTech","Health Tech","Investments","Japan","News","Pharma","Quick Reads","Regional"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/re-air-raises-%c2%a5580m-for-vascular-regeneration-therapy\/","url":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/re-air-raises-%c2%a5580m-for-vascular-regeneration-therapy\/","name":"\u30ea\u30a8\u30a2\u30fc\u3001\u8840\u6db2\u7d30\u80de\u3092\u7528\u3044\u305f\u8840\u7ba1\u6cbb\u7642\u30675\u51048000\u4e07\u5186\u3092\u7372\u5f97","isPartOf":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website"},"primaryImageOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/re-air-raises-%c2%a5580m-for-vascular-regeneration-therapy\/#primaryimage"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/re-air-raises-%c2%a5580m-for-vascular-regeneration-therapy\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/07\/Re-air-Raises-\u00a5580M-for-Vascular-Regeneration-Therapy-01.webp","datePublished":"2025-07-18T13:12:11+00:00","description":"\u9806\u5929\u5802\u5927\u5b66\u767a\u306e\u30b9\u30bf\u30fc\u30c8\u30a2\u30c3\u30d7\u3001\u30ea\u30a8\u30a2\u304c6\u51048500\u4e07\u5186\u3092\u8abf\u9054\u3002.","breadcrumb":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/re-air-raises-%c2%a5580m-for-vascular-regeneration-therapy\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/itbusinesstoday.com\/health-tech\/pharma\/re-air-raises-%c2%a5580m-for-vascular-regeneration-therapy\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/re-air-raises-%c2%a5580m-for-vascular-regeneration-therapy\/#primaryimage","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/07\/Re-air-Raises-\u00a5580M-for-Vascular-Regeneration-Therapy-01.webp","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/07\/Re-air-Raises-\u00a5580M-for-Vascular-Regeneration-Therapy-01.webp","width":1201,"height":800,"caption":"Re-air"},{"@type":"BreadcrumbList","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/re-air-raises-%c2%a5580m-for-vascular-regeneration-therapy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/itbusinesstoday.com\/"},{"@type":"ListItem","position":2,"name":"Re-air Raises \u00a5580M for Vascular Regeneration Therapy"}]},{"@type":"WebSite","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","description":"","publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","width":663,"height":275,"caption":"itbusinesstoday"},"image":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15","name":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png90b3cb23d1d9c08733d969d29ea2d30d","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","caption":"ITBT StaffWriter"},"description":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc\u306f\u3001IT Business Today\u306e\u793e\u5185\u5bc4\u7a3f\u8005\u3067\u3001\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u30cb\u30e5\u30fc\u30b9\u3068QuickBytes\u306e\u914d\u4fe1\u3092\u62c5\u5f53\u3057\u3066\u3044\u307e\u3059\u3002IT\u3001\u30cf\u30a4\u30c6\u30af\u3001\u4f01\u696d\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u6700\u65b0\u52d5\u5411\u3092\u30ab\u30d0\u30fc\u3057\u3001\u7c21\u6f54\u3067\u30a4\u30f3\u30d1\u30af\u30c8\u306e\u3042\u308b\u6700\u65b0\u60c5\u5831\u3092\u8aad\u8005\u306b\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002","sameAs":["https:\/\/itbusinesstoday.com\/"],"url":"https:\/\/itbusinesstoday.com\/ja\/author\/itbt-staffwriter\/"}]}},"authors":[{"term_id":572,"user_id":7,"is_guest":0,"slug":"itbt-staffwriter","display_name":"ITBT StaffWriter","avatar_url":{"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","url2x":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png"},"author_category":"","first_name":"ITBT","last_name":"StaffWriter","user_url":"https:\/\/itbusinesstoday.com\/","job_title":"","description":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc\u306f\u3001IT Business Today\u306e\u793e\u5185\u5bc4\u7a3f\u8005\u3067\u3001\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u30cb\u30e5\u30fc\u30b9\u3068QuickBytes\u306e\u914d\u4fe1\u3092\u62c5\u5f53\u3057\u3066\u3044\u307e\u3059\u3002IT\u3001\u30cf\u30a4\u30c6\u30af\u3001\u4f01\u696d\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u6700\u65b0\u52d5\u5411\u3092\u30ab\u30d0\u30fc\u3057\u3001\u7c21\u6f54\u3067\u30a4\u30f3\u30d1\u30af\u30c8\u306e\u3042\u308b\u6700\u65b0\u60c5\u5831\u3092\u8aad\u8005\u306b\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002"}],"_links":{"self":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/17947","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/comments?post=17947"}],"version-history":[{"count":2,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/17947\/revisions"}],"predecessor-version":[{"id":17962,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/17947\/revisions\/17962"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media\/17956"}],"wp:attachment":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media?parent=17947"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/categories?post=17947"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/tags?post=17947"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/ppma_author?post=17947"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}